How Innovation Leads to Impact: Making Science-Led Treatment Accessible in India
The Intergenerational Impact of Investing in Women’s Health
Our complex generics engine, particularly in respiratory, has matured into a key growth driver
Why continuous learning is the lifeblood of the pharmaceutical industry
Why India Needs A New Playbook For TB Elimination
We are expanding our CDMO capabilities to meet the next wave of complex therapies starting with oncology
Vice President and Global Head – Corporate Communications
